抑制线粒体OMA1可以改善骨髓瘤瘤的发生
Lingyan Chen1, Dejian Chen2, Yiming Pan3
1Department of Orthopedics, Affiliated Qingyuan Hospital, Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong, China. chenlingyan@gzhmu.edu.cn.
Cell death & disease
|November 2, 2024
概括
骨髓瘤 (OS) 瘤发生是由OMA1蛋白酶驱动的. 抑制OMA1会减少瘤生长和转移,这表明OMA1是骨癌的治疗点.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- OMA1是一种金属蛋白酶,对线粒体平衡和癌症发展至关重要.
- 人类骨髓瘤 (OS) 中OMA1的作用尚不清楚.
- OMA1表达水平与各种癌症患者的预后相关.
研究的目的:
- 研究OMA1在骨髓瘤 (OS) 瘤发生中的作用.
- 探索OMA1作为OS的潜在治疗点.
主要方法:
- 在患者衍生OS组织中分析OMA1表达.
- 在体内和体外使用OMA1淘汰OS细胞的研究.
- 对Ki67和Cleaved-caspase的免疫组织化学 3.
- 对PINK1,帕金,p53,GSK3β和β-catenin进行西部斑分析.
- 线粒体ROS水平的评估.
- 用环皮洛克斯 (CPX) 治疗.
主要成果:
- 在先进的OS瘤中观察到高OMA1表达.
- 在小鼠中,OMA1淘汰赛显著降低了OS瘤的生长,体重和肺转移.
- 缺少OMA1导致了亡的增加 (Cleaved-caspase 3) 和增殖的减少 (Ki67).
- OMA1损失通过PINK1/Parkin诱导了过度的线粒,改变了p53定位,减少了ROS和降低了β-catenin信号,抑制了扩散和入侵.
- 抗真菌药物西克洛皮洛克斯通过向OMA1.1,减少了OS瘤的发展.
结论:
- OMA1在骨髓瘤的进展和转移中发挥着关键作用.
- 以OMA1为目标,例如使用西克洛皮洛克斯,有效地抑制OS瘤的生长.
- OMA1是一种有前途的预后标志物和骨髓瘤的治疗点.
更多相关视频
08:07Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.2K
08:47Improved Visualization of Lung Metastases at Single Cell Resolution in Mice by Combined In-situ Perfusion of Lung Tissue and X-Gal Staining of lacZ-Tagged Tumor Cells
Published on: August 21, 2012
17.3K
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
